Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-16

Clinical Trial Update: Electroconvulsive Therapy in Clozapine-resistant Schizophrenia [NA]

View source ↗

Summary

Clinical trial update on using electroconvulsive therapy for clozapine-resistant schizophrenia, covering schizophrenia and schizoaffective disorder indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Electroconvulsive therapy

Snippet

Sponsor: Niuvanniemi Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: UNKNOWN